☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
Aclaris to Divest its Rhofade (oxymetazoline hydrochloride) with all IPR Rights to EPI Health
October 11, 2019
Bayer's G4A Digital Health Partnerships Program Signs an Agreement with Eleven Digital Health Startups Transforming Digital Health...
October 11, 2019
Boehringer Ingelheim's Ofev (nintedanib) Receives the US FDA's Breakthrough Therapy Designation for Chronic Fibrosing ILDs with a...
October 11, 2019
Biocon Biologics Signs an In-License Agreement with Just - Evotec Biologics
October 11, 2019
Alexion Signs an Option to Co-Develop and Commercialize Agreement with Stealth for Elamipretide
October 11, 2019
OraSure Technologies' Rapid Diagnostic OraQuick Ebola Rapid Antigen Test Receives the US FDA Marketing Approval for Detection of E...
October 11, 2019
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions